Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10426
Fate Therapeutics
FATE
$291M
| $199K | ﹤0.01% |
56,761
+3,468
| +7% | +$13.5K |
|
10427
CALL
Corvus Pharmaceuticals
CRVS
$1.19B
| $199K | ﹤0.01% |
37,600
+22,700
| +152% | +$81.5K |
|
10428
CALL
SGHC Ltd
SGHC
$7.02B
| $198K | ﹤0.01% |
54,600
-3,200
| -6% | -$11K |
|
10429
FTAI Infrastructure
FIP
$422M
| $198K | ﹤0.01% |
21,172
-40,735
| -66% | -$378K |
|
10430
Kodak
KODK
$885M
| $198K | ﹤0.01% |
41,975
-121,349
| -74% | -$632K |
|
10431
ProShares UltraShort Real Estate
SRS
$14.2M
| $198K | ﹤0.01% |
4,468
-5,300
| -54% | -$271K |
|
10432
CALL
Patria Investments
PAX
$1.83B
| $198K | ﹤0.01% |
17,700
+2,400
| +16% | +$28.5K |
|
|
PFD
10433
Flaherty & Crumrine Preferred and Income Fund
PFD
$145M
| $197K | ﹤0.01% |
+16,520
| New | +$184K |
|
10434
PUT
Orthofix Medical
OFIX
$395M
| $197K | ﹤0.01% |
12,600
-5,200
| -29% | -$83.3K |
|
10435
YieldMax Innovation Option Income Strategy ETF
OARK
$47.7M
| $197K | ﹤0.01% |
3,714
+779
| +27% | +$40.5K |
|
10436
Voyager Therapeutics
VYGR
$218M
| $197K | ﹤0.01% |
33,613
-23,153
| -41% | -$168K |
|
|
ALCY
10437
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
| $197K | ﹤0.01% |
18,057
+3,167
| +21% | +$34.2K |
|
10438
PUT
AudioCodes
AUDC
$242M
| $197K | ﹤0.01% |
20,200
-4,600
| -19% | -$47.9K |
|
10439
Horizon Bancorp
HBNC
$1B
| $196K | ﹤0.01% |
12,636
+1,121
| +10% | +$16.7K |
|
10440
CALL
Playtika
PLTK
$885M
| $196K | ﹤0.01% |
24,800
-6,900
| -22% | -$51.8K |
|
|
GB
10441
CALL
DELISTED
Global Blue Group Holding
GB
| $196K | ﹤0.01% |
35,800
+400
| +1% | +$2.02K |
|
10442
PUT
Olema Pharmaceuticals
OLMA
$899M
| $196K | ﹤0.01% |
16,400
-8,100
| -33% | -$104K |
|
10443
Payoneer
PAYO
$2.41B
| $195K | ﹤0.01% |
25,893
+4,000
| +18% | +$26K |
|
|
BHR
10444
CALL
Braemar Hotels & Resorts
BHR
$139M
| $195K | ﹤0.01% |
+63,000
| New | +$198K |
|
10445
CALL
Nkarta
NKTX
$198M
| $194K | ﹤0.01% |
43,000
-32,400
| -43% | -$184K |
|
10446
Main Thematic Innovation ETF
TMAT
$249M
| $194K | ﹤0.01% |
+10,927
| New | +$186K |
|
10447
El Pollo Loco
LOCO
$466M
| $193K | ﹤0.01% |
14,123
-23,667
| -63% | -$296K |
|
|
GRF
10448
Eagle Capital Growth Fund
GRF
$40.9M
| $193K | ﹤0.01% |
19,565
-1,753
| -8% | -$16.7K |
|
10449
E.W. Scripps
SSP
$302M
| $193K | ﹤0.01% |
86,024
-173,739
| -67% | -$445K |
|
10450
PUT
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.34B
| $193K | ﹤0.01% |
+10,700
| New | +$189K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.